Global and China Targeted Cancer Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Targeted Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Novartis

    • Pfizer

    • Sanofi

    • Galapagos

    • Incyte

    • Astellas Pharma

    • AbbVie

    • Gilead

    • Celgene

    • Teva

    • Vertex

    • Eli Lilly

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Cancer Growth Blocker Drug

    • Monoclonal Antibody

    • Other

    Application:

    • Hospitals

    • Academic & Research Institutes

    • Diagnostic & Reference Laboratories

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Targeted Cancer Drugs Industry Overview

      • 1.1.1 Targeted Cancer Drugs Market Scope and Market Segments

      • 1.1.2 Targeted Cancer Drugs Industry Characteristics

      • 1.1.3 Global and China Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Targeted Cancer Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Targeted Cancer Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Cancer Growth Blocker Drug

      • 1.2.2 Monoclonal Antibody

      • 1.2.3 Other

    • 1.3 Global Targeted Cancer Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Academic & Research Institutes

      • 1.3.3 Diagnostic & Reference Laboratories

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Targeted Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Targeted Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Targeted Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Targeted Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Targeted Cancer Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Targeted Cancer Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Targeted Cancer Drugs Industry PEST Analysis

    • 2.3 Targeted Cancer Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Targeted Cancer Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Targeted Cancer Drugs Industry

    Chapter 3 Global and China Targeted Cancer Drugs Market, by Manufacturer

    • 3.1 Global and China Targeted Cancer Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Targeted Cancer Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Targeted Cancer Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Targeted Cancer Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Targeted Cancer Drugs Market Top 3 Players

    Chapter 4 Global and China Targeted Cancer Drugs Market, by Type (2017-2028)

    • 4.1 Targeted Cancer Drugs Market Trend, by Type

    • 4.2 Global Targeted Cancer Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Targeted Cancer Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Targeted Cancer Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Targeted Cancer Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Targeted Cancer Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Targeted Cancer Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Targeted Cancer Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Targeted Cancer Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Targeted Cancer Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Targeted Cancer Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Targeted Cancer Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Targeted Cancer Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Targeted Cancer Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Targeted Cancer Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Targeted Cancer Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Targeted Cancer Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Targeted Cancer Drugs Market Analysis

    • 7.1 North America Targeted Cancer Drugs Market, by Type

    • 7.2 North America Targeted Cancer Drugs Market, by Application

    • 7.3 North America Targeted Cancer Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Targeted Cancer Drugs Market Analysis

    • 8.1 Europe Targeted Cancer Drugs Market, by Type

    • 8.2 Europe Targeted Cancer Drugs Market, by Application

    • 8.3 Europe Targeted Cancer Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Targeted Cancer Drugs Market Analysis

    • 9.1 APAC Targeted Cancer Drugs Market, by Type

    • 9.2 APAC Targeted Cancer Drugs Market, by Application

    • 9.3 APAC Targeted Cancer Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Targeted Cancer Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Targeted Cancer Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Targeted Cancer Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Targeted Cancer Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Targeted Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Targeted Cancer Drugs Company Profiles

      • 11.1 Novartis

        • 11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Novartis Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.1.3 Novartis Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Pfizer

        • 11.2.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Pfizer Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.2.3 Pfizer Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Sanofi

        • 11.3.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Sanofi Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.3.3 Sanofi Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Galapagos

        • 11.4.1 Galapagos Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Galapagos Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.4.3 Galapagos Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Incyte

        • 11.5.1 Incyte Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Incyte Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.5.3 Incyte Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Astellas Pharma

        • 11.6.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Astellas Pharma Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.6.3 Astellas Pharma Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 AbbVie

        • 11.7.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 AbbVie Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.7.3 AbbVie Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Gilead

        • 11.8.1 Gilead Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Gilead Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.8.3 Gilead Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Celgene

        • 11.9.1 Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Celgene Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.9.3 Celgene Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Teva

        • 11.10.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Teva Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.10.3 Teva Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Vertex

        • 11.11.1 Vertex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Vertex Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.11.3 Vertex Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Eli Lilly

        • 11.12.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Eli Lilly Targeted Cancer Drugs Product Profiles, Application and Specification

        • 11.12.3 Eli Lilly Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Targeted Cancer Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Targeted Cancer Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Targeted Cancer Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Targeted Cancer Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Targeted Cancer Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Targeted Cancer Drugs Market Size and Growth Rate of Cancer Growth Blocker Drug (2017-2028)

    • Figure Global Targeted Cancer Drugs Market Size and Growth Rate of Monoclonal Antibody (2017-2028)

    • Figure Global Targeted Cancer Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Targeted Cancer Drugs Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Targeted Cancer Drugs Market Size and Growth Rate of Academic & Research Institutes (2017-2028)

    • Figure Global Targeted Cancer Drugs Market Size and Growth Rate of Diagnostic & Reference Laboratories (2017-2028)

    • Figure North America Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Targeted Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Targeted Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Targeted Cancer Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Targeted Cancer Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Targeted Cancer Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Targeted Cancer Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Targeted Cancer Drugs Market Share, by Manufacturer in 2022

    • Table Global Targeted Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Value, by Type (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Targeted Cancer Drugs Price Trend, by Type (2017-2028)

    • Table China Targeted Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table China Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Targeted Cancer Drugs Sales Value, by Type (2017-2028)

    • Table China Targeted Cancer Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Targeted Cancer Drugs Price Trend, by Type (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Value, by Application (2017-2028)

    • Table Global Targeted Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Targeted Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Table China Targeted Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table China Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Targeted Cancer Drugs Sales Value, by Application (2017-2028)

    • Table China Targeted Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Targeted Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Targeted Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table North America Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Targeted Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table North America Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Targeted Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Targeted Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Targeted Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Targeted Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Targeted Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Targeted Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Targeted Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Targeted Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Galapagos Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Galapagos Product Profiles, Application and Specification

    • Table Galapagos Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Incyte Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Incyte Product Profiles, Application and Specification

    • Table Incyte Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Product Profiles, Application and Specification

    • Table Gilead Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Product Profiles, Application and Specification

    • Table Celgene Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Product Profiles, Application and Specification

    • Table Teva Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Vertex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Vertex Product Profiles, Application and Specification

    • Table Vertex Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Targeted Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.